Sort
21,453 grants matching “tuberculosis”
A novel protein export chaperone of Mycobacterium tuberculosis
$598,742Miriam S. Braunstein · Univ Of North Carolina Chapel Hill · R01 · FY2020 · AI
Novel Inhibitors to DHPS to Probe Catalytic Mechanism & Therapeutic Potential
$598,667Stephen W White · St. Jude Children'S Research Hospital · R01 · FY2008 · AI
Mechanistic investigation of RNA-mediated gene regulation and immunity
$598,623Ailong Ke · Cornell University · R35 · FY2019 · GM
Mechanistic investigation of RNA-mediated gene regulation and immunity
$598,623Ailong Ke · Cornell University · R35 · FY2020 · GM
Longitudinal Study of HIV-Associated Lung Infections in Soweto
$598,562Richard E Chaisson · Johns Hopkins University · R01 · FY2009 · HL
CCR2 in Atherosclerosis and Monocyte Trafficking
$598,311Israel F. Charo · J. David Gladstone Institutes · R01 · FY2007 · HL
Characterization of the nutrient assimilation pathways in M. tuberculosis
$598,288Brian C Vanderven · Cornell University · R01 · FY2024 · AI
Characterization of the nutrient assimilation pathways in M. tuberculosis
$598,288Brian C Vanderven · Cornell University · R01 · FY2023 · AI
DEVELOPMENT AND TESTING OF NEW TUBERCULOSIS VACCINES
$598,148University Of California Los Angeles · R01 · FY2003 · AI
Air Pollution Particle Effects on Human Antimycobacterial Immunity
$597,988Stephan K Schwander · Rbhs-School Of Public Health · R01 · FY2015 · ES
Novel Immunoassays for Mycobacteria Detection in Non-human Primates
$597,851Paul A Luciw · University Of California At Davis · R24 · FY2008 · RR
Tuberculosis epidemiology and novel transmission routes in rural Tanzania
$597,847Philip C Hopewell · University Of California, San Francisco · U01 · FY2014 · AI
Pharmacokinetics of Anti-tuberculosis and Antiretroviral Drugs in Children
$597,608Awewura Jacob Kwara · University Of Florida · R01 · FY2021 · HD
Development of Dual Dopamine/Serotonin Releasing Agents
$597,588Richard Rothman · National Institute On Drug Abuse · Z01 · FY2008 · DA
Cross-Border Dynamics of MDR/XDR-TB Epidemiology by HIV Status in Tijuana, Mexico
$597,502Richard S Garfein · University Of California, San Diego · R56 · FY2009 · AI
Shaping Next Generation Aminoglycoside Antibiotics for Treatment of Multidrug- Resistant Diseases
$597,405David Crich · University Of Georgia · R01 · FY2019 · AI
Options for Delivery of Short-Course Tuberculosis Preventive Therapy: The 3HP Options Trial
$597,392Adithya Cattamanchi · University Of California, San Francisco · R01 · FY2021 · HL
Pharmacology & ImmunoPathology (PIP) Core
$597,325Veronique Dartois · Weill Medical Coll Of Cornell Univ · U19 · FY2025 · AI
Biocontainment Research Support Service(s) Core-Optional
$597,319Sixto Manuel Leal · University Of Alabama At Birmingham · UC7 · FY2025 · AI
DIRECTLY ADMINISTERERD HIV THERAPY IN METHADONE CLINICS
$597,268Johns Hopkins University · R01 · FY2005 · DA
RESEARCH PROJECT 1
$597,169Nevan J Krogan · University Of California, San Francisco · U19 · FY2021 · AI
CORE 2: Technology Core
$597,168Alexander Marson · University Of California, San Francisco · U19 · FY2021 · AI
Dynamics of TB and MDR TB transmission in areas with high HIV prevalence
$597,147Nicola Mario Zetola · University Of Pennsylvania · R01 · FY2012 · AI
Haiti AIDS Research Training: Models to Implementation
$596,960Jean William Pape · Gheskio Center · U2R · FY2009 · TW
Mechanisms of anti-fungal Vaccine immunity
$596,957Bruce Steven Klein · University Of Wisconsin-Madison · R01 · FY2021 · AI